Literature DB >> 12682247

APCs present A beta(k)-derived peptides that are autoantigenic to type B T cells.

Scott B Lovitch1, James J Walters, Michael L Gross, Emil R Unanue.   

Abstract

Type B T cells recognize peptide provided exogenously but are ignorant of the same epitope derived from intracellular processing. In this study, we demonstrate the existence of type B T cells to an abundant autologous peptide derived from processing of the I-A(k) beta-chain. T cell hybridomas raised against this peptide fail to recognize syngeneic APC despite abundant presentation of the naturally processed epitope but react in a dose-dependent manner to exogenous peptide. Moreover, these hybridomas respond to Abeta(k) peptide extracted from the surface of I-A(k)-expressing APC. This peptide was isolated from B cell lines where it was found in high abundance; it was also present in lines lacking HLA-DM, but in considerably lower amounts. Therefore, type B T cells exist in the naive repertoire to abundant autologous peptides. We discuss the implications of these findings to the potential biological role of type B T cells in immune responses and autoimmune pathology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682247     DOI: 10.4049/jimmunol.170.8.4155

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity.

Authors:  Cristina C Clement; Aniuska Becerra; Liusong Yin; Valerio Zolla; Liling Huang; Simone Merlin; Antonia Follenzi; Scott A Shaffer; Lawrence J Stern; Laura Santambrogio
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

Review 2.  Antigen presentation: lysoyme, autoimmune diabetes, and Listeria--what do they have in common?

Authors:  Emil Unanue; Craig Byersdorfer; Javier Carrero; Matteo Levisetti; Scott Lovitch; Zheng Pu; Anish Suri
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.

Authors:  Kazuyuki Kawamura; Katherine A McLaughlin; Robert Weissert; Thomas G Forsthuber
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

4.  B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.

Authors:  Chelsea R Parker Harp; Angela S Archambault; Julia Sim; Stephen T Ferris; Robert J Mikesell; Pandelakis A Koni; Michiko Shimoda; Christopher Linington; John H Russell; Gregory F Wu
Journal:  J Immunol       Date:  2015-04-20       Impact factor: 5.422

Review 5.  The melting pot of the MHC II peptidome.

Authors:  Lawrence J Stern; Laura Santambrogio
Journal:  Curr Opin Immunol       Date:  2016-03-25       Impact factor: 7.486

6.  Presentation of type B peptide-MHC complexes from hen egg white lysozyme by TLR ligands and type I IFNs independent of H2-DM regulation.

Authors:  Beverly S I Strong; Emil R Unanue
Journal:  J Immunol       Date:  2011-07-25       Impact factor: 5.422

Review 7.  Unconventional recognition of peptides by T cells and the implications for autoimmunity.

Authors:  James F Mohan; Emil R Unanue
Journal:  Nat Rev Immunol       Date:  2012-09-07       Impact factor: 53.106

8.  Unconventional T-cell recognition of an arthritogenic epitope of proteoglycan aggrecan released from degrading cartilage.

Authors:  Jane Falconer; Rahul Mahida; Divya Venkatesh; Jeffrey Pearson; John H Robinson
Journal:  Immunology       Date:  2015-12-21       Impact factor: 7.397

9.  Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes.

Authors:  James F Mohan; Matteo G Levisetti; Boris Calderon; Jeremy W Herzog; Shirley J Petzold; Emil R Unanue
Journal:  Nat Immunol       Date:  2010-02-28       Impact factor: 25.606

Review 10.  A step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cells.

Authors:  Scheherazade Sadegh-Nasseri
Journal:  F1000Res       Date:  2016-06-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.